MiRAVA Therapeutics Email Formats

Biotechnology Research • Edinburgh, Scotland, United Kingdom • 1-10 Employees

Key Contact at MiRAVA Therapeutics

Vlad Miscianinov

Director

Company overview

Headquarters	Edinburgh, Scotland, United Kingdom
Website	miravatherapeutics.com
NAICS	541714
Keywords	Biotechnology, Gene Therapy, Wound Healing
Founded	2023
Employees	1-10

About MiRAVA Therapeutics

MiRAVA Therapeutics is developing miRHeal Pro, an advanced wound care solution aimed at healing chronic, non-healing ulcers. miRHeal Pro leverages cutting-edge microRNA technology to promote vascularisation and accelerate wound healing. By directly targeting key molecular pathways that hinder wound repair, it offers a novel approach to restoring tissue health and addressing chronic ulcers effectively. Our mission is to drive innovation in healthcare by creating therapies that improve patient outcomes, enhance quality of life, and help reduce the financial burden on healthcare systems.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Funding Data

MiRAVA Therapeutics has never raised funding before.

Frequently asked questions

MiRAVA Therapeutics is located in Edinburgh, Scotland, GB.

MiRAVA Therapeutics was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.

MiRAVA Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at MiRAVA Therapeutics

Vlad Miscianinov

Director

4.8

40,000 users